Kuehn Law Investigates Potential Breach of Fiduciary Duties by QuidelOrtho Corporation Officers and Directors New York, Nov. 13, 2024 /PRNewswire/ — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of QuidelOrtho Corporation (NASDAQ: QDEL) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, QuidelOrtho insiders…

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Acadia Healthcare Company, Inc. Los Angeles, CA / ACCESSWIRE / November 13, 2024 The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. (“Acadia” or “the Company”) (NASDAQ:ACHC) for violations of 10(b)…

NioCorp Announces Successful Private Placement with Gross Proceeds of $35 Million Subscribers in the Private Placement Include Certain NioCorp Officers and Directors for Gross Proceeds of Approximately $0.42 Million On November 13, 2024, NioCorp Developments Ltd. (“NioCorp” or the “Company”) (Nasdaq:NB) announced the successful completion of a non-brokered private placement, raising a total of $35…

The Growing Uranium Ore Market: A Promising Future Ahead Overview of Uranium Ore Market Growth The uranium ore market is set to experience significant growth in the coming years, according to a report from the Business Research Company. The market size is projected to increase from $1.11 billion in 2023 to $1.21 billion in 2024,…

Johnson & Johnson’s Oncology Franchise Flourishes in 2024 Darzalex Sales Soar in Third Quarter In the second half of 2024, Johnson & Johnson made significant progress in developing its oncology franchise. One of the standout achievements was the impressive growth in sales of Darzalex, a key drug in the company’s portfolio. In the third quarter…

Results from Adaptimmune Therapeutics’ IGNYTE-ESO Trial Introduction Adaptimmune Therapeutics plc (NASDAQ: ADAP) recently released data from the primary analysis of its pivotal Phase 2 IGNYTE-ESO trial of lete-cel. The trial focused on individuals with synovial sarcoma or myxoid/round cell liposarcoma (MRCLS) who had previously undergone anthracycline-based therapy. Key Findings The results of the study showed…

Montana Technologies Changes Name to AirJoule Technologies: A New Era of Innovation RONAN, Mont., Nov. 13, 2024 (GLOBE NEWSWIRE) Big news in the tech world! Montana Technologies Corporation, a company known for its groundbreaking AirJoule® technology for atmospheric water harvesting, has rebranded itself as AirJoule Technologies Corporation. This change marks a significant shift for the…